Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

CYLERT

PEMOLINE

Standard Dose
37.5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview CYLERT is listed in Drugs@FDA under application 017703 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient PEMOLINE Form and strength TABLET, CHEWABLE;ORAL - 37.5MG Sponsor ABBOTT Submission history Latest submission status date: 2003-11-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview CYLERT is listed in Drugs@FDA under application 017703 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient PEMOLINE Form and strength TABLET, CHEWABLE;ORAL - 37.5MG Sponsor ABBOTT Submission history Latest submission status date: 2003-11-21 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.